PAS
HRMY icon

Point72 Asia (Singapore)’s Harmony Biosciences HRMY Stock Holding History

Point72 Asia (Singapore)’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,508
Closed -$118K – 1230
2024
Q1 		$118K Buy
3,508
+2,829
+417% +$90.8K 0.03% 593
2023
Q4 		$21.9K Buy
+679
New +$19K 0.01% 445

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asia (Singapore)'s HRMY Position: Q2 2024 in Review

Point72 Asia (Singapore) sold out of Harmony Biosciences (HRMY) in Q2 2024, closing a stake of 3,508 shares — an estimated $118K sold.

Point72 Asia (Singapore) first reported a position in HRMY in Q4 2023 and held it in 2 quarters. The position peaked at $118K in Q1 2024. 219 funds tracked by Wall St. Rank hold HRMY as of Q2 2024.

  • Point72 Asia (Singapore) reported no remaining Harmony Biosciences position as of Q2 2024 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 3,508 Harmony Biosciences shares in Q2 2024, an estimated $118K.
  • Point72 Asia (Singapore) first reported a position in Harmony Biosciences in Q4 2023 and held it in 2 quarters.
  • Point72 Asia (Singapore)'s Harmony Biosciences position peaked at $118K in Q1 2024.
  • 219 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2024.

Based on Point72 Asia (Singapore)'s 13F filing for Q2 2024, filed 14 Aug 2024.